Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 177

Similar articles for PubMed (Select 3417974)

1.

Use of intravenous amiodarone for emergency treatment of life-threatening ventricular arrhythmias.

Helmy I, Herre JM, Gee G, Sharkey H, Malone P, Sauve MJ, Griffin JC, Scheinman MM.

J Am Coll Cardiol. 1988 Oct;12(4):1015-22.

2.

Long-term results of amiodarone therapy in patients with recurrent sustained ventricular tachycardia or ventricular fibrillation.

Herre JM, Sauve MJ, Malone P, Griffin JC, Helmy I, Langberg JJ, Goldberg H, Scheinman MM.

J Am Coll Cardiol. 1989 Feb;13(2):442-9.

3.

Efficacy and tolerance of high-dose intravenous amiodarone for recurrent, refractory ventricular tachycardia.

Mooss AN, Mohiuddin SM, Hee TT, Esterbrooks DJ, Hilleman DE, Rovang KS, Sketch MH Sr.

Am J Cardiol. 1990 Mar 1;65(9):609-14.

PMID:
2178383
4.

Long-term efficacy, safety and survival of patients with potentially lethal ventricular arrhythmias treated with low-dose amiodarone.

Kerin NZ, Rubenfire M, Blevins RD, Frumin H, Faitel K, Jarandilla R, Aragon E, Marinescu G, Luarca R.

Clin Cardiol. 1988 Mar;11(3 Suppl 2):II31-40.

PMID:
3271193
6.

Amiodarone in patients with previous drug-mediated torsade de pointes. Long-term safety and efficacy.

Mattioni TA, Zheutlin TA, Sarmiento JJ, Parker M, Lesch M, Kehoe RF.

Ann Intern Med. 1989 Oct 1;111(7):574-80.

PMID:
2774388
8.

Arrhythmias in the intensive care patient.

Trappe HJ, Brandts B, Weismueller P.

Curr Opin Crit Care. 2003 Oct;9(5):345-55. Review.

PMID:
14508146
9.

Toxic and therapeutic effects of amiodarone in the treatment of cardiac arrhythmias.

Greene HL, Graham EL, Werner JA, Sears GK, Gross BW, Gorham JP, Kudenchuk PJ, Trobaugh GB.

J Am Coll Cardiol. 1983 Dec;2(6):1114-28.

PMID:
6685151
10.
11.
12.

Evaluation of amiodarone therapy in the treatment of drug-resistant cardiac arrhythmias: long-term follow-up.

Peter T, Hamer A, Mandel WJ, Weiss D.

Am Heart J. 1983 Oct;106(4 Pt 2):943-50.

PMID:
6613841
13.

Clinical efficacy of amiodarone in treatment of recurrent ventricular tachycardia and ventricular fibrillation.

Heger JJ, Prystowsky EN, Zipes DP.

Am Heart J. 1983 Oct;106(4 Pt 2):887-94.

PMID:
6613835
14.

Long-term follow-up of patients requiring intravenous amiodarone to suppress hemodynamically destabilizing ventricular arrhythmias.

Fogel RI, Herre JM, Kopelman HA, Kowey PR, Trohman RG, Fineberg N, Prystowsky EN.

Am Heart J. 2000 Apr;139(4):690-5.

PMID:
10740153
15.

Five-year follow-up of 589 patients treated with amiodarone.

Weinberg BA, Miles WM, Klein LS, Bolander JE, Dusman RE, Stanton MS, Heger JJ, Langefeld C, Zipes DP.

Am Heart J. 1993 Jan;125(1):109-20.

PMID:
8417505
16.
18.

Clinical pharmacokinetics and efficacy of amiodarone for refractory tachyarrhythmias.

Haffajee CI, Love JC, Canada AT, Lesko LJ, Asdourian G, Alpert JS.

Circulation. 1983 Jun;67(6):1347-55.

PMID:
6851030
19.

Amiodarone treatment in patients with ventricular arrhythmias.

Prystowsky EN, Heger JJ, Miles WM, Zipes DP.

Drugs. 1985 Mar;29 Suppl 3:47-52.

PMID:
3996245
20.

Nonsustained ventricular tachycardia as a predictor for sudden death in patients with idiopathic dilated cardiomyopathy. The role of amiodarone treatment.

Castelli G, Ciaccheri M, Cecchi F, Troiani V, Nannini M, Marconi P, Olivotto J, Montereggi A, Dolara A.

G Ital Cardiol. 1999 May;29(5):514-23.

PMID:
10367218
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk